Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy

Journal of NeuroVirology

Volumn 6, Issue 5, 2000, Pages 398-409

  Vaz, Beatriz ^a   Cinque, Paola ^b   Pickhardt, Marcus ^a   Weber, Thomas ^a  

^a Marienkrankenhaus Hamburg   (Germany)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Direct sequencing; DNA binding motif; JCV; PCR; PML; Transcriptional control region

Indexed keywords

NUCLEAR FACTOR I; NUCLEOTIDE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BINDING SITE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMYELINATING DISEASE; DNA BINDING; DNA SEQUENCE; GENE AMPLIFICATION; GENE CONSTRUCT; GENE DELETION; GENE DUPLICATION; GENE INSERTION; GENE REARRANGEMENT; GENE SEQUENCE; GLIA CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; JC VIRUS; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROSPECTIVE STUDY; TRANSCRIPTION REGULATION; URINALYSIS; VIRUS REPLICATION;

EID: 0033813018     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009018304     Document Type: Article

References (66)

1. JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: Increased frequency of JCV type 2 in PML
2. Co-infection with two JC virus genotypes in brain, cerebrospinal fluid or urinary tract detected by direct cycle sequencing of PCR products
3. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals
4. Regulation of a human neurotropic virus promoter, JCVE: Identification of a novel activator domain located upstream from the 98 bp enhancer promoter region
5. Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes
6. Polymerase chain reaction strategy
7. Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells
8. Type-specific amplification of viral DNA using touchdown and hot start PCR
9. Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences
10. Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure
11. Progressive multifocal leukoencephalopathy
12. Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals
13. Evidence that the soluble factors secreted by activated immune cells suppress replication of human neurotropic JC virus DNA in glial cells
14. The role of a pentanucleotide repeat sequence, AGGGAAGGGA, in the regulation of JC virus DNA replication
15. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system
16. Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid
17. Adenovirus DNA replication in vitro: Site-directed mutagenesis of the nuclear factor I binding site of the Ad2 origin
18. Linker scan analysis of the early regulatory region of human papovavirus BK
19. Molecular biology and pathogenesis of human polyomavirus infections
20. Evidence of human polyomavirus BK and JC infection in normal brain tissue
21. Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue
22. Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients
23. Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction
24. Human polyomavirus JC virus genome
25. The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy
26. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: High potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy
27. The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain
28. Regulation of the glial-specific JC virus early promoter by the transcription factor Sp1
29. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy
30. Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy
31. The possible viral etiology of multiple sclerosis
32. A recombinant cDNA derived from human brain encodes a DNA binding protein that stimulates transcription of the human neurotropic virus JCV
33. Alteration in the JC polyomavirus genome is enhanced in immunosuppressed renal transplant patients
34. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy
35. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals
36. The JC virus minimal core promoter is glial cell specific in vivo
37. A 70- to 80-kDa glial cell protein interacts with the AGGGAAGGGA domain of the JC virus early promoter only in the presence of the neighboring cis DNA elements
38. Human JC virus nuclear factor 1 binding motifs and large tumor antigen region required for transactivation of late promoter
39. Human JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells
40. Recognition site of nuclear factor I, a sequence-specific DNA-binding protein from HeLa cells that stimulates adenovirus DNA replication
41. Identification of critical elements within the JC virus DNA replication origin
42. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
43. Differences in regulatory sequences of naturally occurring JC virus variants
44. Detection of archetype and rearranged variants of JC virus in multiple tissues from a pediatric PML patient
45. Identification of JC virus variants in multiple tissues of pediatric and adult PML patients
46. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy
47. Soluble factors secreted by activated T-lymphocytes modulate the transcription of the immunosuppressive cytokine TGF-beta 2 in glial cells
48. Transcriptional regulation: Lessons from the human neurotropic polyomavirus, JCV
49. Role of viruses in the etiopathogenesis of multiple sclerosis
50. Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines
51. Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis
52. Amplification of JC virus regulatory DNA sequences from cerebrospinal fluid: Diagnostic value for progressive multifocal leukoencephalopathy
53. Expression of multiple classes of the Nuclear Factor-1 family in the developing human brain: Differential expression of two classes of NF-1 genes
54. Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation
55. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature
56. Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system
57. Progressive multifocal leukoencephalopathy: Molecular biology, pathogenesis and clinical impact
58. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy
59. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC Virus-specific DNA from Cerebrospinal fluid
60. Regulation of JC virus by the POU-domain transcription factor Tst-1: Implications for progressive multifocal leukoencephalopathy
61. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy
62. Occurrence of multiple JC virus variants with distinctive regulatory sequences in the brain of a single patient with progressive multifocal leukoencephalopathy
63. Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients
64. Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals
65. Isolation and characterization of a type II JC virus from a brain biopsy of a patient with PML
66. Particles resembling papovavirions in human cerebral demyelinating disease